Chargement en cours...
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
SIMPLE SUMMARY: In 2021, the identification of effective biomarkers became a major focus of prostate cancer (PCa) in order to improve outcomes and select potentially responsive patients. The aim of this contribution is to review the main 2021 novelties in prognostic and therapeutic markers in PCa, w...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307279/ https://ncbi.nlm.nih.gov/pubmed/34298683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143471 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|